Skip to content
Recall Observatory FDA recall evidence

Drug product

Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North Wales, PA 19454, NDC 0093-1177-01

D-1473-2022

August 23, 2022

Class II

Product summary

Firm
Teva Pharmaceuticals USA Inc
Event
Event 90792
Status
Terminated
Classification
Class II
Quantity
Unavailable
Official record key
drug-enforcement:D-1473-2022

Official wording

Reason: CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.

Code information: Lot #: 3007830, 3007746, 3007829, Exp. Date 10/2024

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    foreign matter
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations